From breeding farms to trading platforms, from racetracks to conservation programs — genomics-driven decision making at every critical point
Pre-breeding whole-genome screening for stallions and broodmares. Covers 8+ hereditary diseases including HYPP, PSSM, and MH with Clear / Carrier / At-Risk tri-state evaluation for evidence-based breeding decisions.
NCDS v3.4 model-based prediction of athletic aptitude across sprint, endurance, dressage, and jumping disciplines. Supports training direction decisions and purchase evaluations with data-backed insights.
Individual genetic fingerprinting based on 40.15M+ variant positions. Enables breed identification, parentage verification, and pedigree purity analysis — providing molecular-level evidence for registration and trading.
Independent third-party genomic verification for equine transactions — covering hereditary health status, pedigree authenticity, and athletic potential assessment. Eliminating information asymmetry between buyers and sellers.
Genomic data support for indigenous breed conservation. Establishing genetic diversity baselines, informing conservation strategies, and providing population structure analysis for genetic resource protection programs.
Causal regulatory network and phenotype prediction-powered breeding optimization. Balancing hereditary disease risk, athletic performance, and conformation traits across multiple dimensions for optimal mating combinations.
